Feb 20, Matthew Holt
The last few months have been dominated by the issue of costs in health care, particularly the costs paid by consumers who thought they had coverage. But it turns out that “surprise billing” isn’t that much of a surprise. The data is clear. Health care costs overall are going up because the speed at which providers, pharma et al. are increasing prices exceeds the reduction in volume that’s being seen in the use of most health services. The lesson of previous decades has been that health care companies can push the line as far as they like, even to beyond what looks like outright fraud, and nothing much will change.
Feb 18, Dan Linton
Next on The Health Data Goldilocks Dilemma, Dan explains that compliance with HIPAA and the CCPA is obviously critical, but this is only the first step. As healthcare begins to embrace big tech and the incredible promise those partnerships can bring, the medical industry must think far beyond legal compliance and embrace real data privacy principles as core operating commitments and key competitive differentiators. The healthcare industry has the opportunity right now to build upon its history of patient trust, but that opportunity won’t be realized by simply maintaining the status quo.
Feb 14, Talal Hilal
On February 12, it was announced that USMLE Step 1 scoring will be changed to pass/fail. Talal, an international medical graduate (IMG) himself, argues that this change may be a blessing in disguise for IMGs. Sure, those who score 2 SDs above the mean on their Step 1 will be at a disadvantage, but that will be the case for all applicants. A pass/fail test means that the panic-inducing hurdle causing IMGs to take 1-3 years after graduating from medical school just to study for Step 1 will be removed. IMGs can focus on the Step 2 CK (which is more relevant anyway) and maybe spend time reading Tolstoy instead of memorizing the names of the rotator cuff muscles and their insertion site on the humeral head.